Journal
STEM CELL REPORTS
Volume 15, Issue 6, Pages 1347-1361Publisher
CELL PRESS
DOI: 10.1016/j.stemcr.2020.10.013
Keywords
-
Categories
Funding
- Federal Ministry of Education and Research (BMBF) [03VP01220]
- SMWK, state of Saxony [TG70]
- DFG, Cluster of Excellence (CRTD)
- TU Dresden CRTD
- DZNE Helmholtz
- HGF [ExNet-0007-Phase2]
Ask authors/readers for more resources
Phagocytosis is a key function in various cells throughout the body. A deficiency in photoreceptor outer segment (POS) phagocytosis by the retinal pigment epithelium (RPE) causes vision loss in inherited retinal diseases and possibly age-related macular degeneration. To date, there are no effective therapies available aiming at recovering the lost phagocytosis function. Here, we developed a high-throughput screening assay based on RPE derived from human embryonic stem cells (hRPE) to reveal enhancers of POS phagocytosis. One of the hits, ramoplanin (RM), reproducibly enhanced POS phagocytosis and ensheathment in hRPE, and enhanced the expression of proteins known to regulate membrane dynamics and ensheathment in other cell systems. Additionally, RM rescued POS internalization defect in Mer receptor tyrosine kinase (MERTK) mutant hRPE, derived from retinitis pigmentosa patient induced pluripotent stem cells. Our platform, including a primary phenotypic screening phagocytosis assay together with orthogonal assays, establishes a basis for RPE-based therapy discovery aiming at a broad patient spectrum.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available